Cancer treatment systems maker BSD Medical Corp. (BSDM) reported that its MicroThermX Microwave Ablation System was showcased at the recent “Fire, Ice and Beyond” symposia. The innovative therapy system was featured at the Utah-based company’s exhibition booth at the symposia, held in Las Vegas, Nevada.
Recognized by the Accreditation Council for Continuing Medical Education, Fire, Ice and Beyond is an international oncology educational symposia. The event provided an insight into the new, advanced energy sources for tumor ablation.
BSD Medical used the symposia to introduce its innovative MicroThermX ablation system to physicians focused on the rapidly growing field of interventional oncology. The physicians at the meet had hands-on experience in using the MicroThermX system in lab simulated ablations of liver tissue.
The MicroThermX system leverages BSD Medical’s proprietary synchronous phased array technology to deliver precision-guided microwave energy to ablate soft tissues using a single-patient-use disposable antenna. The company spokesman presented the latest advancements in this technology at the symposia.
The MicroThermX system hit the U.S. and European markets in December 2010 and January 2011, respectively. The minimally-invasive MicroThermX system has been developed to provide treatments as a stand-alone therapy and has applications in open surgical and percutaneous (via needle-puncture of the skin) ablation procedures. As such, it can be used by both surgeons and interventional radiologists.
BSD Medical competes with established players like Boston Scientific (BSX) and Angiodynamics (ANGO) in the thermal ablation market. The global market for soft tissue ablation has been estimated to exceed $2.3 billion, offering a significant opportunity for BSD Medical.
ANGIODYNAMICS (ANGO): Free Stock Analysis Report
BOSTON SCIENTIF (BSX): Free Stock Analysis Report
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment